Analysis of p53 Tumor Suppressor Gene in Families with Multiple Glioma Patients

[1]  J. Isola,et al.  High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas , 2000, Neuropathology and applied neurobiology.

[2]  K. Hemminki,et al.  Cancers in the first-degree relatives of children with brain tumours , 2000, British Journal of Cancer.

[3]  R. Jenkins,et al.  Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. , 2000, American journal of medical genetics.

[4]  M. Roncalli,et al.  An Ava I polymorphism in the TP53 gene. , 1999, Molecular and cellular probes.

[5]  H. Grönberg,et al.  Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study , 1999, International journal of cancer.

[6]  P. Kleihues,et al.  Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations , 1998, Journal of neuropathology and experimental neurology.

[7]  D. Evans,et al.  Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. , 1997, Cancer research.

[8]  R Miike,et al.  Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.

[9]  J. Bruner,et al.  Correlation of p53 immunoreactivity and sequencing in patients with glioma , 1996, Molecular carcinogenesis.

[10]  G. Thomas,et al.  Incidence of germ‐line p53 mutations in patients with gliomas , 1995, International journal of cancer.

[11]  D. Louis,et al.  Hereditary Tumor Syndromes of the Nervous System: Overview and Rare Syndromes , 1995, Brain pathology.

[12]  P. Kleihues,et al.  Familial Brain Tumour Syndrome Associated with a p53 Germline Deletion of Codon 236 , 1995, Brain pathology.

[13]  T. Visakorpi,et al.  Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.

[14]  H. Saya,et al.  Germline p53 gene mutations in subsets of glioma patients. , 1994, Journal of the National Cancer Institute.

[15]  A. Craft,et al.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.

[16]  J. Cairncross,et al.  Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma , 1994, Annals of neurology.

[17]  W. Cavenee,et al.  Gliomas in Families , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  H. Saya,et al.  Codon 72 polymorphism of the TP53 gene. , 1990, Nucleic acids research.

[19]  J. Flannery,et al.  Cancer in relatives of children with central-nervous-system neoplasms. , 1984, The New England journal of medicine.

[20]  L. Schuman,et al.  Epidemiology of primary central nervous system neoplasms. II. Case-control study. , 1970, American journal of epidemiology.

[21]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[22]  D. Louis,et al.  Glioblastoma multiforme in four siblings: A cytogenetic and molecular genetic study , 2005, Journal of Neuro-Oncology.

[23]  P. Kleihues,et al.  Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.

[24]  K. Tamura,et al.  Germline p53 mutation at codon 133 in a cancer-prone family , 1997, Journal of Molecular Medicine.